Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus.

We infused small doses of insulin (0.3 mU per kilogram of body weight per minute; range, 0.9 to 1.7 U per hour) for three hours into 8 subjects who did not have diabetes, 11 patients with well-controlled diabetes (hemoglobin A1, 7.6 +/- 0.7 percent), and 10 patients with poorly controlled diabetes (hemoglobin A1, 11.5 +/- 1.7 percent) to simulate the mild peripheral hyperinsulinemia observed during insulin treatment. Normoglycemia was established in the patients during the night before study. During the insulin infusion, the plasma glucose level stabilized at 60 to 70 mg per deciliter (3.3 to 3.9 mmol per liter) in the subjects without diabetes and the patients with poorly controlled diabetes, because of a rebound increase in hepatic glucose production. In contrast, hypoglycemia developed in the patients with well-controlled diabetes (42 +/- 2 mg of glucose per deciliter, or 2.3 +/- 0.1 mmol per liter, P less than 0.01) as glucose production remained suppressed. The hypoglycemia in the patients with well-controlled diabetes was associated with a lowering of the plasma threshold of glucose that triggered a release of epinephrine (less than 45 mg of glucose per deciliter, or 2.5 mmol per liter, vs. greater than 55 mg per deciliter, or 3.1 mmol per liter, in the other groups, P less than 0.01) as well as an enhanced sensitivity to the suppressive effects of insulin on hepatic glucose production. Nearly identical disturbances in glucose counterregulation and decreased perception of hypoglycemia developed when four of the subjects with poorly controlled diabetes were restudied after intensive treatment. We conclude that strict control of diabetes induces physiologic alterations (delayed release of epinephrine and persistent suppression of glucose production) that impair glucose counterregulation to doses of insulin in the therapeutic range. These defects may contribute to the increased incidence of severe hypoglycemia reported during intensive insulin therapy.

[1]  A. Cherrington,et al.  Effect of glucagon on glucose production during insulin deficiency in the dog. , 1978, The Journal of clinical investigation.

[2]  S. Genuth,et al.  Diabetes Control and Complications Trial (DCCT): Results of Feasibility Study. The DCCT Research Group , 1987, Diabetes Care.

[3]  P. Brunetti,et al.  Abnormal Glucose Counterregulation in Insulin-dependent Diabetes Mellitus: Interaction of Anti-Insulin Antibodies and Impaired Glucagon and Epinephrine Secretion , 1983, Diabetes.

[4]  N. Christensen,et al.  Hormonal, Metabolic, and Cardiovascular Responses to Hypoglycemia in Diabetic Autonomic Neuropathy , 1981, Diabetes.

[5]  R. Sherwin,et al.  Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. , 1979, The Journal of clinical investigation.

[6]  U. Smith,et al.  Importance of Glucose Control for the Recovery from Hypoglycemia in Insulin-dependent Diabetics , 1982, Diabetes.

[7]  J. Tobin,et al.  Effects of arterial versus venous sampling on analysis of glucose kinetics in man. , 1976, Journal of applied physiology.

[8]  W. Clarke,et al.  Overnight Basal Insulin Requirements in Fasting Insulin-dependent Diabetics , 1980, Diabetes.

[9]  P. Cryer,et al.  Blood Glucose Regulates the Effects of Insulin and Counterregulatory Hormones on Glucose Production In Vivo , 1979, Diabetes.

[10]  R. Unger,et al.  Pancreatic glucagon secretion in normal and diabetic subjects. , 1969, The American journal of the medical sciences.

[11]  F. Greenwood,et al.  Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity , 1962, Nature.

[12]  K. Godfrey.  Comparing the Means of Several Groups , 1985, Medical Uses of Statistics.

[13]  K. Mashimo,et al.  A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated Patients , 1973, Diabetes.

[14]  W. Kerner,et al.  Incidence of Hypoglycemic Episodes in Diabetic Patients Under Continuous Subcutaneous Insulin Infusion and Intensified Conventional Insulin Treatment: Assessment by Means of Semiambulatory 24-hour Continuous Blood Glucose Monitoring , 1985, Diabetes Care.

[15]  D L Horwitz,et al.  Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.

[16]  P. Brunetti,et al.  Effects of Long-Term Optimization and Short-Term Deterioration of Glycemic Control on Glucose Counterregulation in Type I Diabetes Mellitus , 1984, Diabetes.

[17]  Effect of improved glycemic control by continuous subcutaneous insulin infusion on hormonal responses to insulin-induced hypoglycemia in type 1 diabetics. , 2009, Acta medica Scandinavica.

[18]  W. Tamborlane,et al.  Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. , 1979, The New England journal of medicine.

[19]  A. Lazarow,et al.  Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats , 1963, Diabetes.

[20]  R. Rizza,et al.  Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. , 1979, The Journal of clinical investigation.

[21]  P. Cryer,et al.  Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. , 1983, The New England journal of medicine.

[22]  K. Polonsky,et al.  Lack of Glucagon Response to Hypoglycemia in Type I Diabetics After Long-Term Optimal Therapy with a Continuous Subcutaneous Insulin Infusion Pump , 1983, Diabetes.

[23]  P. Brunetti,et al.  Role of hepatic autoregulation in defense against hypoglycemia in humans. , 1985, The Journal of clinical investigation.

[24]  R. DeFronzo,et al.  Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes. , 1985, Annals of internal medicine.

[25]  H Keen,et al.  Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. , 1978, British medical journal.

[26]  R. DeFronzo,et al.  Improved Insulin Sensitivity in Patients with Type I Diabetes Mellitus After CSII , 1985, Diabetes.

[27]  R. Hoeldtke,et al.  Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. , 1982, Annals of internal medicine.

[28]  R. Rizza,et al.  Observations on C-Peptide and Free Insulin in the Blood During Continuous Subcutaneous Insulin Infusion and Conventional Insulin Therapy , 1985, Diabetes.